ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Lectroid
|
9.8K |
4.3M |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9.8K
|
4.3M
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
129 |
59K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
129
|
59K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
Lectroid
|
3 |
686 |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
3
|
686
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
129 |
59K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
129
|
59K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
129 |
59K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
129
|
59K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
19 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
Lectroid
|
20 |
3.9K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20
|
3.9K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
Lectroid
|
20 |
3.9K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20
|
3.9K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
10 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
2 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelation to treat obesity?
|
|
Lectroid
|
4 |
1.2K |
4 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
4
|
1.2K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
Lectroid
|
24 |
6.1K |
6 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
24
|
6.1K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
Lectroid
|
34 |
7.3K |
6 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
34
|
7.3K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
1.9K |
680K |
13 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.9K
|
680K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
HYPED UP TO THE MAX
|
|
Lectroid
|
87 |
20K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
87
|
20K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
HYPED UP TO THE MAX
|
|
Lectroid
|
87 |
20K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
87
|
20K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
4.9K |
1.3M |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
4.9K |
1.3M |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
4.9K |
1.3M |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
Lectroid
|
9 |
2.3K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.3K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
Lectroid
|
9 |
2.3K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.3K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
91K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
4.9K |
1.3M |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
4.9K |
1.3M |
3 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
8 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
0 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
9 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
91K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
12 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
297
|
91K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
29 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
91K
|
29
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
91K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
91K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Lectroid
|
946 |
470K |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
946
|
470K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
Lectroid
|
91 |
50K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
91
|
50K
|
6
|
|